These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 2887615

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Famotidine in the therapy of gastric hypersecretory states.
    Vinayek R, Howard JM, Maton PN, Wank SA, Slaff JI, Gardner JD, Jensen RT.
    Am J Med; 1986 Oct 24; 81(4B):49-59. PubMed ID: 2877575
    [Abstract] [Full Text] [Related]

  • 4. Parenteral control of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
    Vinayek R, Hahne WF, Euler AR, Norton JA, Jensen RT.
    Dig Dis Sci; 1993 Oct 24; 38(10):1857-65. PubMed ID: 8104773
    [Abstract] [Full Text] [Related]

  • 5. Recent advances in the management of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
    Maton PN, Gardner JD, Jensen RT.
    Gastroenterol Clin North Am; 1989 Dec 24; 18(4):847-63. PubMed ID: 2575602
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [24-hour intragastric acid profile in a ZES patient with H2 blockers].
    Dammann HG, Müller P, Simon B, Kommerell B.
    Z Gastroenterol; 1984 Jun 24; 22(6):318-20. PubMed ID: 6147052
    [No Abstract] [Full Text] [Related]

  • 10. Parenteral antisecretory drug therapy in patients with Zollinger-Ellison syndrome.
    Saeed ZA, Norton JA, Frank WO, Young MD, Maton PN, Gardner JD, Jensen RT.
    Gastroenterology; 1989 Jun 24; 96(6):1393-402. PubMed ID: 2565842
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of ranitidine and cimetidine in the treatment of gastric hypersecretion.
    Collen MJ, Howard JM, McArthur KE, Raufman JP, Cornelius MJ, Ciarleglio CA, Gardner JD, Jensen RT.
    Ann Intern Med; 1984 Jan 24; 100(1):52-8. PubMed ID: 6318628
    [Abstract] [Full Text] [Related]

  • 13. Treatment of Zollinger-Ellison syndrome with exploratory laparotomy, proximal gastric vagotomy, and H2-receptor antagonists. A prospective study.
    Richardson CT, Peters MN, Feldman M, McClelland RN, Walsh JH, Cooper KA, Willeford G, Dickerman RM, Fordtran JS.
    Gastroenterology; 1985 Aug 24; 89(2):357-67. PubMed ID: 2861140
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Ranitidine and cimetidine in Zollinger-Ellison syndrome.
    Mignon M, Vallot T, Mayeur S, Bonfils S.
    Br J Clin Pharmacol; 1980 Aug 24; 10(2):173-4. PubMed ID: 6107118
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [The role of H2 antagonists in Zollinger-Ellison syndrome].
    Dammann HG, Walter TA, Müller P, Simon B.
    Clin Ter; 1984 Dec 15; 111(5):393-400. PubMed ID: 6151434
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of curative gastrinoma resection on gastric secretory function and antisecretory drug requirement in the Zollinger-Ellison syndrome.
    Pisegna JR, Norton JA, Slimak GG, Metz DC, Maton PN, Gardner JD, Jensen RT.
    Gastroenterology; 1992 Mar 15; 102(3):767-78. PubMed ID: 1537514
    [Abstract] [Full Text] [Related]

  • 20. Effectiveness of omeprazole in seven patients with Zollinger-Ellison syndrome resistant to histamine H2-receptor antagonists.
    Delchier JC, Soule JC, Mignon M, Goldfain D, Cortot A, Travers B, Isal JP, Bader JP.
    Dig Dis Sci; 1986 Jul 15; 31(7):693-9. PubMed ID: 2873001
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.